| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |